MOS
60
2
PX
69
-3
PFE
23
-5
MAT
52
-3
SLG
56
4
FMC
30
-3
FRT
50
-6
MCHP
62
11
AMZN
58
2
K
54
-5
KMI
71
2
PNC
65
-2
ZTS
33
-3
TRV
45
-4
LNC
60
7
NSC
73
23
XRX
56
-3
WBA
50
2
EXC
69
2
LOW
53
-3
MOS
60
2
PX
69
-3
PFE
23
-5
MAT
52
-3
SLG
56
4
FMC
30
-3
FRT
50
-6
MCHP
62
11
AMZN
58
2
K
54
-5
KMI
71
2
PNC
65
-2
ZTS
33
-3
TRV
45
-4
LNC
60
7
NSC
73
23
XRX
56
-3
WBA
50
2
EXC
69
2
LOW
53
-3
Financhill
Back

Tonix Pharmaceuticals Holding Stock Predictions

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
30

TNXP
Tonix Pharmaceuticals Holding

Last Price:
$19.08
Seasonality Move:
-14.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Tonix Pharmaceuticals Holding Stock Forecast

  • Over the next 52 weeks, Tonix Pharmaceuticals Holding has on average historically fallen by 28.4% based on the past 13 years of stock performance.
  • Tonix Pharmaceuticals Holding has fallen lower in 12 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 92.31%
  • Is Tonix Pharmaceuticals Holding Stock Undervalued?
    The current Tonix Pharmaceuticals Holding [TNXP] share price is $18.83. The Score for TNXP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • TNXP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Tonix Pharmaceuticals Holding Stock Go Up Next Year?

  • Over the next 52 weeks, Tonix Pharmaceuticals Holding has on average historically fallen by 28.4% based on the past 13 years of stock performance.

Tonix Pharmaceuticals Holding Stock Rating

Sell
30
Tonix Pharmaceuticals Holding (TNXP) is a Sell

Is Tonix Pharmaceuticals Holding overpriced?

  • Tonix Pharmaceuticals Holding has fallen lower in 12 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 92.31%

Tonix Pharmaceuticals Holding Stock Price History

Is TNXP stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TNXP is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tonixpharma.com

52-Week Data

52-Week High:
672.00
52-Week Low:
6.76

Prediction Charts

Market Cap:
121.2M
Price in USD:
18.83
Volume:
452.2K
Beta:
2.51

Technical Analysis

SMA50:
17.38
SMA100:
21.90
SMA200:
22.87
52-Wk Change:
-96.77%

Stock Predictions

  • Is Tonix Pharmaceuticals Holding stock public?
    Yes, Tonix Pharmaceuticals Holding is a publicly traded company.
  • What is the Tonix Pharmaceuticals Holding stock quote today?
    The Tonix Pharmaceuticals Holding stock price is 18.83 USD today.
  • How to buy Tonix Pharmaceuticals Holding stock online?
    You can buy Tonix Pharmaceuticals Holding shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-22 14.80 14.96 15.08 14.35
Apr-23 15.47 16.95 17.65 15.38
Apr-24 17.57 17.19 18.54 16.78
Apr-25 17.05 17.82 18.74 16.83
Apr-28 17.49 17.03 17.84 16.70
Apr-29 16.99 17.40 17.96 16.93
Apr-30 17.15 18.02 18.26 16.68
May-1 18.21 18.04 18.95 17.60
May-2 18.11 20.00 20.24 18.11
May-5 20.00 19.58 21.99 19.53
May-6 19.60 18.88 20.38 18.55
May-7 18.92 19.14 19.72 18.82
May-8 19.25 18.94 19.43 18.60
May-9 19.15 18.83 19.94 18.45

Tonix Pharmaceuticals Holding Earnings

Tonix Pharmaceuticals Holding Earnings Report: Per Share Tonix Pharmaceuticals Holding Earnings Q1 Q2 Q3 and Q4 last year and next year.

Tonix Pharmaceuticals Holding Forecast Revenue Growth

Tonix Pharmaceuticals Holding Stock Analysis: Historical quarterly revenues per share for Tonix Pharmaceuticals Holding and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $733.01 per share, an increase next quarter of $0.83 per share, a decrease this year of $8.50 per share, and an increase next year of $7.22 per share.

* Tonix Pharmaceuticals Holding stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.